Quality Control Teams Increasingly Mandate Documented Barrier Data
Global flexible packaging and pharmaceutical film quality control teams increasingly mandate documented barrier-performance consistency and shelf-life correction data directly within procurement contracts, citing genuine reliability-validation and total-cost-of-ownership demand that undocumented untested components cannot credibly address across scaled Chinese and American operator fleets worldwide today. This specification trend has become a stronger award catalyst than general cost marketing alone in several major packaging categories recently across the wider industry overall. Quality control teams who documented barrier-performance consistency early now command stronger positioning across most purchase and renewal cycles worldwide today, reinforcing supplier loyalty broadly.
Market Impact: Lifts demand by 4 pct








